JMJD2D (human recombinant)


  • Specification
  • Related Products
Cat.No.:  PE-1911
Product Name:  JMJD2D (human recombinant)
Description:  Methylation of lysine residues in core histones plays a critical role in regulating gene expression. Jumonji domain containing 2D (JMJD2D) catalyzes the demethylation of di- and tri-methylated forms of histone H3 at lysine residue 9 (me 2/3), leading to transcriptional repression and activation, respectively. Like other JmjC protein hydroxylase family members, JMJD2D is an α-ketoglutarate-dependent Fe (II) oxygenase. Because of their implication in cancer cell growth, jumonji C domain-containing histone demethylase inhibitors may have the capacity to be anticancer agents.
Storage:  Store at 4℃ if entire vial will be used within 2-4 weeks. Store at -20℃ or -80℃ for longer periods of time. Avoid multiple freeze-thaw cycles.
Molecular Weight:  42.7 kDa
Purity:  ≥75% (by SDS-PAGE)
Species:  human
Formulation:  A solution in 50 mM HEPES, pH 7.4, containing 150 mM sodium chloride and 20% glycerol
Accession#:  Q6B0I6
Alternative Names:  Jumonji Domain Containing 2D;Lysine-Specific Demethylase 4D;KDM4D
Tag:  His
Expression System:  E. coli
Warning:  This product is for research use only. Not for use in diagnostic or therapeutic procedures.

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.